OraSure Technologies received a $7.5 million contract to develop a rapid antigen test for Marburg Virus Disease. OraSure Technologies, Inc. announced it received a $7.5 million award through the Rapid ...

(RTTNews) - OraSure Technologies, Inc. (OSUR), a medical device company, on Monday announced that it has secured funding from the U.S. Department of Health and Human Services' Biomedical Advanced ...

The medical technology company, which makes diagnostic tests and sample collection devices used in healthcare, has unveiled ...

OraSure Technologies Inc. (Bethlehem, PA) has taken another step toward seeking FDA approval for home use of its OraQuick Advance rapid HIV test. In March, the company announced that it had contracted ...

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended ...

BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...